COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalised patients.The ministry included dexamethasone as an option for treatment along with antiviral drug remdesivir in a recent revision to its handbook.
The revision was widely reported by Japanese media on Wednesday.In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic.Japan's Nichi-Iko Pharmaceutical Co is among those that produce the drug.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.Click here to read the.